Crossref
Recent advances in understanding the clinical utility and underlying cause of antinucleosome (antichromatin) autoantibodies
Clinical and Applied Immunology Reviews · 2004
DOI: 10.1016/j.cair.2004.04.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Applied Immunology Reviews, 2004. Verfasst von Rufus W Burlingame. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Burlingame, R. W. (2004). Recent advances in understanding the clinical utility and underlying cause of antinucleosome (antichromatin) autoantibodies. Clinical and Applied Immunology Reviews. https://doi.org/10.1016/j.cair.2004.04.002
Vancouver
Burlingame RW. Recent advances in understanding the clinical utility and underlying cause of antinucleosome (antichromatin) autoantibodies. Clinical and Applied Immunology Reviews. 2004. doi:10.1016/j.cair.2004.04.002
BibTeX
@article{Burlingame2004,
author = {Burlingame, Rufus W},
title = {Recent advances in understanding the clinical utility and underlying cause of antinucleosome (antichromatin) autoantibodies},
journal = {Clinical and Applied Immunology Reviews},
year = {2004},
doi = {10.1016/j.cair.2004.04.002}
}
EUVIMED